Department of Orthopaedic Surgery, University of Texas Health Science Center at San Antonio, San Antonio, TX; and.
Department of Orthopaedic Surgery, San Antonio Military Medical Center, Fort Sam Houston, TX.
J Orthop Trauma. 2022 Sep 1;36(Suppl 4):S31-S35. doi: 10.1097/BOT.0000000000002427.
Orthopaedic trauma demonstrates a relatively high rate of surgical site infections (SSI) as compared with other surgical specialties. SSIs provide significant clinical challenges and create significant health care costs. Incisional negative pressure wound therapy (iNPWT) has reduced the risk of SSI in orthopaedic surgery and other surgical specialties.
The purpose of this study is to investigate potential cost savings with the use of iNPWT (3M Prevena Therapy, 3M, St. Paul, MN) in high-risk orthopaedic trauma patients with closed OTA/AO 41C and 43C fractures.
This is a retrospective cohort study performed at a single, level-1 trauma center using data from a lower extremity fracture registry. Using the results from the registry and baseline infection rates derived from the literature, a health economic model was developed to evaluate the potential cost savings.
A total of 79 patients included in the registry underwent open reduction and internal fixation of OTA/AO 41C and 43C fractures. A total of 10.1% developed a SSI. For those who received iNPWT, the rate of SSI was 7.4%. A health economic model suggests that the use of iNPWT may reduce the costs per patient by approximately $1381 to $4436 per patient.
This health economic assessment and model suggests that judicious use of iNPWT may reduce health care costs in patients undergoing open reduction and internal fixation of OTA/AO 41C and 43C fractures.
Economic Level IV.
与其他外科专业相比，矫形创伤显示出相对较高的手术部位感染（SSI）发生率。SSI 会带来严重的临床挑战，并造成巨大的医疗保健成本。切口负压伤口治疗（iNPWT）降低了矫形外科和其他外科专业的 SSI 风险。
本研究旨在探讨 iNPWT（3M Prevena Therapy，3M，圣保罗，明尼苏达州）在闭合 OTA/AO 41C 和 43C 骨折的高危矫形创伤患者中的使用是否具有潜在的成本节约。
这是一项在单一一级创伤中心进行的回顾性队列研究，使用下肢骨折登记处的数据。利用登记处的结果和从文献中得出的基线感染率，建立了一个健康经济模型，以评估潜在的成本节约。
登记处共纳入 79 例接受 OTA/AO 41C 和 43C 骨折切开复位内固定术的患者。共有 10.1%的患者发生 SSI。接受 iNPWT 的患者 SSI 发生率为 7.4%。健康经济模型表明，iNPWT 的使用可能使每位患者的成本降低约 1381 美元至 4436 美元。
这项健康经济学评估和模型表明，明智地使用 iNPWT 可能会降低接受 OTA/AO 41C 和 43C 骨折切开复位内固定术患者的医疗保健成本。
经济水平 IV。
